Cargando…

Celecoxib attenuates hepatosteatosis by impairing de novo lipogenesis via Akt‐dependent lipogenic pathway

Mounting evidence indicates that hepatic de novo lipogenesis is a common abnormality in non‐alcoholic fatty liver disease (NAFLD) patients. We investigated whether a selective COX‐2 inhibitor, celecoxib, alleviates hepatic steatosis by targeting an Akt‐driven lipogenic pathway. We estimated the effi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Cong, Lu, Yuzhen, Song, Yingying, Chen, Liang, Hu, Junjie, Meng, Yan, Chen, Xin, Li, Shan, Zheng, Guohua, Qiu, Zhenpeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279593/ https://www.ncbi.nlm.nih.gov/pubmed/35713152 http://dx.doi.org/10.1111/jcmm.17435

Ejemplares similares

MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis
por: Wu, Heng, et al.
Publicado: (2016)

Celecoxib attenuates hepatocellular proliferative capacity during hepatocarcinogenesis by modulating a PTEN/NF-κB/PRL-3 pathway
por: Zhang, Cong, et al.
Publicado: (2019)

Obesity-Associated Hepatosteatosis and Impairment of Glucose Homeostasis Are Attenuated by Haptoglobin Deficiency
por: Lisi, Simonetta, et al.
Publicado: (2011)

Direct Visualization of De novo Lipogenesis in Single Living Cells
por: Li, Junjie, et al.
Publicado: (2014)

Comparative Approach of the de novo Fatty Acid Synthesis (Lipogenesis) between Ruminant and Non Ruminant Mammalian Species: From Biochemical Level to the Main Regulatory Lipogenic Genes
por: Laliotis, G.P., et al.
Publicado: (2010)

Celastrol delays hepatic steatosis and carcinogenesis in a rapid AKT/c-Met-transfected hepatocellular carcinoma model via suppressing fatty acid synthase expression and AKT/ERK phosphorylation
por: Hu, Junjie, et al.
Publicado: (2018)

Urolithin A Attenuates Hyperuricemic Nephropathy in Fructose-Fed Mice by Impairing STING-NLRP3 Axis-Mediated Inflammatory Response via Restoration of Parkin-Dependent Mitophagy
por: Zhang, Cong, et al.
Publicado: (2022)

Detection of Impaired Cognitive Function in Rat with Hepatosteatosis Model and Improving Effect of GLP-1 Analogs (Exenatide) on Cognitive Function in Hepatosteatosis
por: Erbaş, Oytun, et al.
Publicado: (2014)

De Novo Lipogenesis Products and Endogenous Lipokines
por: Yilmaz, Mustafa, et al.
Publicado: (2016)

Desaturation index versus isotopically measured de novo lipogenesis as an indicator of acute systemic lipogenesis
por: Harding, Scott V, et al.
Publicado: (2015)

Expanding Roles of De Novo Lipogenesis in Breast Cancer
por: Simeone, Pasquale, et al.
Publicado: (2021)

DAXX drives de novo lipogenesis and contributes to tumorigenesis
por: Mahmud, Iqbal, et al.
Publicado: (2023)

mTORC2-AKT signaling to ATP-citrate lyase drives brown adipogenesis and de novo lipogenesis
por: Martinez Calejman, C., et al.
Publicado: (2020)

An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth
por: Liu, Liu, et al.
Publicado: (2021)

Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis via gut microbiota
por: Liu, Meng-Ting, et al.
Publicado: (2019)

Genetic variants in de novo lipogenic pathway genes predict the prognosis of surgically-treated hepatocellular carcinoma
por: Jiang, Hequn, et al.
Publicado: (2015)

Retinal de novo lipogenesis coordinates neurotrophic signaling to maintain vision
por: Rajagopal, Rithwick, et al.
Publicado: (2018)

Adipocyte-derived Periostin mediates glucocorticoid-induced hepatosteatosis in mice
por: Wan, Jian, et al.
Publicado: (2019)

Wnt signaling, de novo lipogenesis, adipogenesis and ectopic fat
por: Song, Kangxing, et al.
Publicado: (2014)

Regulation and Metabolic Significance of De Novo Lipogenesis in Adipose Tissues
por: Song, Ziyi, et al.
Publicado: (2018)

FASN-dependent de novo lipogenesis is required for brain development
por: Gonzalez-Bohorquez, Daniel, et al.
Publicado: (2022)

Fructose drives de novo lipogenesis affecting metabolic health
por: Geidl-Flueck, Bettina, et al.
Publicado: (2023)

Ceramides: Nutrient Signals that Drive Hepatosteatosis
por: Summers, Scott A.
Publicado: (2020)

Upregulation of WDR6 drives hepatic de novo lipogenesis in insulin resistance in mice
por: Yao, Zhenyu, et al.
Publicado: (2023)

Author Correction: mTORC2-AKT signaling to ATP-citrate lyase drives brown adipogenesis and de novo lipogenesis
por: Calejman, C. Martinez, et al.
Publicado: (2020)

De novo lipogenesis in metabolic homeostasis: More friend than foe?
por: Solinas, Giovanni, et al.
Publicado: (2015)

Growth Hormone Inhibits Hepatic De Novo Lipogenesis in Adult Mice
por: Cordoba-Chacon, Jose, et al.
Publicado: (2015)

Sex Differences in Hepatic De Novo Lipogenesis with Acute Fructose Feeding
por: Low, Wee Suan, et al.
Publicado: (2018)

Biguanides Induce Acute de novo Lipogenesis in Human Primary Sebocytes
por: Nicoll, James, et al.
Publicado: (2020)

Gene expressions of de novo hepatic lipogenesis in feline hepatic lipidosis
por: Valtolina, Chiara, et al.
Publicado: (2019)

OR17-01 Leptin Decreases De Novo Lipogenesis in Lipodystrophic Patients
por: Baykal, Annah Petek, et al.
Publicado: (2020)

Deficiency of peroxisomal NUDT7 stimulates de novo lipogenesis in hepatocytes
por: Song, Jinsoo, et al.
Publicado: (2022)

Oleic acid differentially affects de novo lipogenesis in adipocytes and hepatocytes
por: Castillo, Hannah B., et al.
Publicado: (2023)

De novo lipogenesis fuels adipocyte autophagosome and lysosome membrane dynamics
por: Rowland, Leslie A., et al.
Publicado: (2023)

PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis
por: Zhang, Wenjie, et al.
Publicado: (2015)

Hepatosteatosis from Lysosomal Acid Lipase Deficiency
por: Zandanell, Stephan, et al.
Publicado: (2018)

Role of hepatosteatosis in the prognosis of COVID 19 disease
por: Çoraplı, Mahmut, et al.
Publicado: (2021)

Diphlorethohydroxycarmalol Attenuates Palmitate-Induced Hepatic Lipogenesis and Inflammation
por: Cha, Seon-Heui, et al.
Publicado: (2020)

Impaired Adipose Tissue Expandability and Lipogenic Capacities as Ones of the Main Causes of Metabolic Disorders
por: Moreno-Indias, Isabel, et al.
Publicado: (2015)

Nicotinamide Phosphoribosyl Transferase (Nampt) Is Required for De Novo Lipogenesis in Tumor Cells
por: Bowlby, Sarah C., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_02jj1p1j59ddru437e3jkkd6pg